ネクセラファーマの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2020/09/04 | 1,341 | 1,366 | 1,308 | 1,336 | -31 | -2.3% | 1,472,400 |
| 2020/09/03 | 1,305 | 1,373 | 1,285 | 1,367 | +73 | +5.6% | 1,694,600 |
| 2020/09/02 | 1,315 | 1,317 | 1,281 | 1,294 | -8 | -0.6% | 978,200 |
| 2020/09/01 | 1,295 | 1,302 | 1,253 | 1,302 | +16 | +1.2% | 1,214,300 |
| 2020/08/31 | 1,275 | 1,298 | 1,268 | 1,286 | +22 | +1.7% | 979,600 |
| 2020/08/28 | 1,320 | 1,331 | 1,249 | 1,264 | -59 | -4.5% | 1,807,400 |
| 2020/08/27 | 1,380 | 1,389 | 1,323 | 1,323 | -56 | -4.1% | 1,214,900 |
| 2020/08/26 | 1,375 | 1,404 | 1,358 | 1,379 | -1 | -0.1% | 723,500 |
| 2020/08/25 | 1,370 | 1,392 | 1,360 | 1,380 | +15 | +1.1% | 1,041,500 |
| 2020/08/24 | 1,407 | 1,407 | 1,333 | 1,365 | -39 | -2.8% | 1,646,100 |
| 2020/08/21 | 1,408 | 1,431 | 1,382 | 1,404 | +10 | +0.7% | 906,500 |
| 2020/08/20 | 1,421 | 1,421 | 1,385 | 1,394 | -35 | -2.4% | 787,600 |
| 2020/08/19 | 1,429 | 1,442 | 1,419 | 1,429 | +4 | +0.3% | 629,700 |
| 2020/08/18 | 1,395 | 1,434 | 1,393 | 1,425 | +50 | +3.6% | 1,145,400 |
| 2020/08/17 | 1,379 | 1,382 | 1,352 | 1,375 | -8 | -0.6% | 787,000 |
| 2020/08/14 | 1,400 | 1,417 | 1,371 | 1,383 | -42 | -2.9% | 928,600 |
| 2020/08/13 | 1,425 | 1,446 | 1,419 | 1,425 | +11 | +0.8% | 537,000 |
| 2020/08/12 | 1,400 | 1,423 | 1,399 | 1,414 | +14 | +1% | 468,700 |
| 2020/08/11 | 1,396 | 1,412 | 1,380 | 1,400 | +23 | +1.7% | 503,000 |
| 2020/08/07 | 1,387 | 1,392 | 1,359 | 1,377 | -9 | -0.6% | 517,200 |
| 2020/08/06 | 1,402 | 1,404 | 1,376 | 1,386 | -21 | -1.5% | 589,700 |
| 2020/08/05 | 1,436 | 1,440 | 1,395 | 1,407 | -29 | -2% | 580,200 |
| 2020/08/04 | 1,400 | 1,436 | 1,400 | 1,436 | +45 | +3.2% | 703,200 |
| 2020/08/03 | 1,380 | 1,406 | 1,368 | 1,391 | +20 | +1.5% | 567,600 |
| 2020/07/31 | 1,371 | 1,422 | 1,361 | 1,371 | -5 | -0.4% | 794,800 |
| 2020/07/30 | 1,352 | 1,390 | 1,343 | 1,376 | +26 | +1.9% | 695,400 |
| 2020/07/29 | 1,404 | 1,420 | 1,345 | 1,350 | -46 | -3.3% | 1,296,400 |
| 2020/07/28 | 1,475 | 1,478 | 1,391 | 1,396 | -82 | -5.5% | 1,559,200 |
| 2020/07/27 | 1,506 | 1,521 | 1,476 | 1,478 | -47 | -3.1% | 1,008,700 |
| 2020/07/22 | 1,548 | 1,553 | 1,520 | 1,525 | -30 | -1.9% | 521,700 |
| 2020/07/21 | 1,550 | 1,587 | 1,541 | 1,555 | +26 | +1.7% | 695,900 |
| 2020/07/20 | 1,520 | 1,543 | 1,498 | 1,529 | +5 | +0.3% | 830,200 |
| 2020/07/17 | 1,561 | 1,580 | 1,515 | 1,524 | -33 | -2.1% | 726,600 |
| 2020/07/16 | 1,565 | 1,600 | 1,557 | 1,557 | -5 | -0.3% | 791,900 |
| 2020/07/15 | 1,553 | 1,572 | 1,552 | 1,562 | +23 | +1.5% | 493,100 |
| 2020/07/14 | 1,556 | 1,575 | 1,539 | 1,539 | -20 | -1.3% | 314,500 |
| 2020/07/13 | 1,544 | 1,570 | 1,514 | 1,559 | +37 | +2.4% | 564,500 |
| 2020/07/10 | 1,545 | 1,585 | 1,503 | 1,522 | -22 | -1.4% | 881,000 |
| 2020/07/09 | 1,579 | 1,580 | 1,544 | 1,544 | -18 | -1.2% | 589,300 |
| 2020/07/08 | 1,553 | 1,588 | 1,544 | 1,562 | +12 | +0.8% | 774,600 |
| 2020/07/07 | 1,531 | 1,600 | 1,506 | 1,550 | +13 | +0.8% | 1,508,800 |
| 2020/07/06 | 1,517 | 1,571 | 1,517 | 1,537 | +26 | +1.7% | 727,900 |
| 2020/07/03 | 1,527 | 1,543 | 1,493 | 1,511 | -16 | -1% | 1,073,700 |
| 2020/07/02 | 1,580 | 1,601 | 1,500 | 1,527 | -33 | -2.1% | 2,112,600 |
| 2020/07/01 | 1,597 | 1,620 | 1,556 | 1,560 | -174 | -10% | 3,867,300 |
| 2020/06/30 | 1,755 | 1,762 | 1,660 | 1,734 | +25 | +1.5% | 1,432,700 |
| 2020/06/29 | 1,825 | 1,830 | 1,700 | 1,709 | -140 | -7.6% | 1,791,700 |
| 2020/06/26 | 1,890 | 1,956 | 1,822 | 1,849 | -28 | -1.5% | 4,219,200 |
| 2020/06/25 | 1,665 | 1,937 | 1,653 | 1,877 | +207 | +12.4% | 7,963,600 |
| 2020/06/24 | 1,697 | 1,700 | 1,657 | 1,670 | -23 | -1.4% | 638,000 |
1001～
1050
件表示中 / 4944件
類似銘柄と比較する
現在ご覧いただいている「ネクセラファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ネクセラファーマ | 125,100円 | +197.7% | - | 0.00% | 51.12倍 | 1.63倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| ゼリア新薬 | 233,800円 | +9.6% | +17.5% | 1.97% | 13.21倍 | 1.30倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 鳥居薬 | 393,500円 | +11.1% | +20.6% | 3.05% | 23.05倍 | 0.92倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| 杏林製薬 | 153,100円 | +3.2% | +4.5% | 3.40% | 17.59倍 | 0.67倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| 栄研化 | 246,000円 | +7.6% | +57.5% | 2.15% | 19.02倍 | 1.87倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム
